跳至主要内容
临床试验/NCT04555863
NCT04555863已完成不适用

haMSter: a Novel Smartphone Communication Tool for People With MS

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
adherence to device

研究概览

简要总结

haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app for 6 months and be asked to fill out the PRO questionnaires on their Smartphone.

Endpoints include the adherence to this app and satisfaction with this Intervention.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Any MS according to MacDonald criteria
  • informed consent

排除标准

  • language barriers

结局指标

主要结局

adherence to device

时间窗: over the course of this study (over 6 months)

Percentage (Number) of participants having completed all necessary questionnaires per study period. Max: 6 completions.

次要结局

  • General satisfaction with specific Features of the haMSter app(after study completion (after 6 months))
  • Overall satisfaction with this application in telemedicine(after study completion (after 6 months))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Patrick Altmann MD PhD

Principal Investigator

Medical University of Vienna

研究点 (2)

Loading locations...

相似试验

haMSter: a Novel Smartphone Communication Tool for... | 临床试验